首页|Data on Artificial Intelligence Reported by Andreas Halman and Colleagues (Artif icial intelligence and psychedelic medicine)
Data on Artificial Intelligence Reported by Andreas Halman and Colleagues (Artif icial intelligence and psychedelic medicine)
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Artificial Intelligenc e is the subject of a report. According to news originating from Victoria, Austr alia, by NewsRx correspondents, research stated, "Artificial intelligence (AI) a nd psychedelic medicines are among the most high-profile evolving disruptive inn ovations within mental healthcare in recent years. Although AI and psychedelics may not have historically shared any common ground, there exists the potential f or these subjects to combine in generating innovative mental health treatment ap proaches." Our news journalists obtained a quote from the research, "In order to inform our perspective, we conducted a scoping review of relevant literature up to late Au gust 2024 via PubMed intersecting AI with psychomedical use of psychedelics. Our perspective covers the potential application of AI in psychedelic medicine for: drug discovery and clinical trial optimization (including pharmacodynamics); st udy design; understanding psychedelic experiences; personalization of treatments ; clinical screening, delivery, and follow-up (potentially delivered via chatbot s/apps); application of psychological preparation, integration, and general ment al health support; its role in enhancing treatment via brain modulatory devices (including virtual reality and haptic suits); and the consideration of ethical a nd security safeguards. Challenges include the need for sufficient data protecti on and security, and a range of necessary ethical protections."
VictoriaAustraliaAustralia and New Z ealandArtificial IntelligenceCybersecurityEmerging TechnologiesHealth an d MedicineMachine LearningMental Health Diseases and Conditions